Join us in New Orleans or via simulcast for a 2-hour live, CME-certified satellite symposium on diagnosing and managing amyloid light-chain (AL) amyloidosis. You will gain insights from a panel of experts on diagnostic approaches for early and accurate diagnosis of AL amyloidosis, managing newly diagnosed and relapsed disease, monitoring treatment response, and optimal strategies for supportive therapy.

Attend in-person or via virtual simulcast.
Agenda Outline:
Serene and Francis During Named Professor
Professor of Medicine
Division of Hematology
Department of Medicine
Mayo Clinic
Rochester, Minnesota
Associate Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
Medical College of Wisconsin
Attending Physician
Froedtert & Medical College of Wisconsin Cancer Center
Milwaukee, Wisconsin
Associate Professor of Oncology and Medicine
Barbara Ann Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, Michigan

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
Designation of Credit
CCO designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Clinical Care Options, LLC. is committed to providing a safe and healthy environment for all our learners. Our decisions and preventive measures are guided by the requirements and recommendations of the CDC alongside federal, state, and local health authorities. We work with each program venue to implement preventive measures to reduce the potential spread of COVID-19. In addition, in accordance with The American Society of Hematology’s (ASH) COVID-19 protocols, all in-person learners will be asked to wear a mask and present their ASH conference badge -OR- proof of vaccination* AND government-issued ID to gain admittance to Acute Lymphoblastic Leukemia Data and Case Discussion on the Use of Asparaginase Therapy in Young and Older Adults.
For more information on ASH’s vaccination and mask requirements, please visit: ASH’S website
*If you do not have your vaccination record card, find other ways to verify you have been vaccinated.
Friday Satellite Symposium on “Advances in the Treatment of T-Cell Lymphomas: A Forum for Data and Case Discussion”, preceding the 64th ASH Annual Meeting and Exposition.
Provided by Clinical Care Options, LLC
Supported by educational grants from
Alexion Pharmaceuticals
Janssen Biotech, Inc. administered by
Janssen Scientific Affairs, LLC.